Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

56.56
Delayed Data
As of Mar 04
 +0.10 / +0.18%
Today’s Change
47.36
Today|||52-Week Range
61.90
-1.65%
Year-to-Date

Stock Price Forecast

The 22 analysts offering 12-month price forecasts for Teva Pharmaceutical have a median target of 65.00, with a high estimate of 70.00 and a low estimate of 49.00. The median estimate represents a +14.92% increase from the last price of 56.56.

Analyst Recommendations

The current consensus among 29 polled investment analysts is to Buy stock in Teva Pharmaceutical. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$1.25
Sales
$4.8B
Reporting Date
Apr 30

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -4.80%
 
 
 
 
 
 
Growthannually 1.35%
 
 
 
 
 
 

Sales

Growthquarterly -6.89%
 
 
 
 
 
 
Growthannually -4.55%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account